Overview
Kay Willborn practices in Oldenburg, Germany. Their top areas of expertise are Lung Cancer, EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Marginal Zone Lymphoma (MZL), and Hysterectomy.
Their clinical research consists of co-authoring 16 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cervical CancerWillborn isExperienced. Learn about Cervical Cancer.
- EGFR Positive Lung CancerWillborn isExperienced. Learn about EGFR Positive Lung Cancer.
- HysterectomyWillborn isExperienced. Learn about Hysterectomy.
- Lung CancerWillborn isExperienced. Learn about Lung Cancer.
- Marginal Zone Lymphoma (MZL)Willborn isExperienced. Learn about Marginal Zone Lymphoma (MZL).
- Non-Hodgkin LymphomaWillborn isExperienced. Learn about Non-Hodgkin Lymphoma.